Faculty, Staff and Student Publications
Publication Date
8-1-2023
Journal
Laryngoscope Investigative Otolaryngology
Abstract
BACKGROUND: The objective of this study was to evaluate long-term symptom improvements in patients with nasal airway obstruction (NAO) secondary to nasal valve collapse (NVC) following minimally invasive temperature-controlled radiofrequency (TCRF) treatment.
METHODS: A prospective, single-arm, multicenter study in patients >18 years with NAO due to NVC. Inclusion criteria were response to nasal valve dilation (e.g., modified Cottle maneuver) and baseline Nasal Obstruction Symptom Evaluation (NOSE) Scale score ≥60. Patients were treated in the nasal valve region with a TCRF device and followed through 2 years. A responder was ≥20% reduction NOSE Scale score or ≥1 reduction in severity class.
RESULTS: A total of 122 patients were treated and 91 reached 2 years. The mean baseline NOSE Scale score was 80.3 (95% CI, 78.1-82.6). The adjusted mean change in score at 2 years was -45.8 (95% CI, -53.5 to -38.1),
CONCLUSIONS: Minimally invasive TCRF device treatment of the internal nasal valve for NAO is well tolerated and leads to significant and sustained improvement in NAO symptom severity through 2 years, including in patients with both static and dynamic NVC, septal deviation, turbinate enlargement, or prior nasal surgery.
LEVEL OF EVIDENCE: 2b.
Keywords
nasal airway obstruction, nasal valve collapse, NOSE scale, rhinoplasty, septoplasty
PMID
37621275
PMCID
PMC10446315
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Comments
Supplementary Materials
PMID: 37621275